2206 GMT - The rise in China's birth rate should help improve sentiment toward The a2 Milk Company's major infant-formula market, Morgan Stanley analysts say. They warn that tangible impacts on industry volumes are expected to lag the recovery in birth rates, but nonetheless call it out as a likely positive for the Australia-listed producer. They tell clients in a note that China's latest births data implies a 5.8% on-year rise in the number of new babies in 2024. MS has an equal-weight rating and A$5.90 target price on the stock, which is at A$5.81 ahead of the open. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
January 19, 2025 17:06 ET (22:06 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。